Ember LifeSciences
Los Angeles
About Ember LifeSciences
Ember LifeSciences is a healthcare technology company that develops cold chain solutions to support the safe transport of temperature-sensitive medicines, vaccines, and biologics using proprietary temperature control systems. The company’s core offering includes the Ember Cube. This self-refrigerated and cloud-connected shipping container provides continuous temperature monitoring, GPS tracking, and real-time data reporting to maintain drug efficacy during transit. Ember LifeSciences leverages its engineering expertise in thermal management and digital monitoring to develop modular shipping solutions that can replace traditional single-use cold chain packaging, thereby reducing waste. It works with pharmaceutical distributors, specialty pharmacies, and laboratories by enabling visibility and control over critical environmental conditions throughout distribution. The company continues to develop next-generation versions of its devices, incorporating improved insulation and configurable features to support broader supply chain use cases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $75.9M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: emberlifesciences.com
- Phone: (805) 372-1330
Industries & Categories
Biopharma, Health Care, Information Technology, Logistics
Social Profiles
Canonical: https://fsome.com/organization/ember-lifesciences-58971 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.